EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Antibiotic Remodeling of the Gut Microbiota Impairs Host Resistance to Secondary Infection

Miaoyu Li, Ying Chen, Xi Chen, Weili Lu, Jie Liao, Jiaqi Wang, Qiwei Liu, Yanzi Chang, Zeping Xu, Yanye Tu, Yang Zhou, Jing Xue, Binbin Wang, Kang Chen, Keyun Cheng, Chunlai Zeng, Hong Li, Qing Shen

iMetaMed · 2026-06 · 2 (2)

DOI: 10.1002/imm3.70039 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Antibiotics disrupt commensal microbiota, but how this predisposes to secondary infections remains unclear. Metagenomic and whole‐transcriptome sequencing were employed to analyze alterations in microbial compositions and host defense. Fecal microbiota transplantation (FMT) and pathogen infection experiments were performed to identify the effects of antibiotics on host. Gut microbial dynamics induced by four antibiotic classes, revealed distinct taxonomic and functional shifts. Vancomycin and ampicillin enriched antibiotic resistance genes and impaired pathogen clearance via FMT. Vancomycin triggered overgrowth of opportunistic pathogens and increased genes of virulence factors, exacerbating colonic inflammation. Metronidazole selectively enriched Enterococcus avium , which correlated with MHC class I upregulation and impaired gut barrier function, promoting systemic Salmonella dissemination. LncRNA NR_166682.1 mediated E. avium ‐induced barrier damage and immune dysregulation, as validated in colon organoids. Antibiotics compromise host resistance through microbiota‐dependent mechanisms, with vancomycin and metronidazole exhibiting distinct, detrimental profiles via enrichment of resistant pathobionts or barrier‐disrupting species, respectively.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →